<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01772888</url>
  </required_header>
  <id_info>
    <org_study_id>12-103</org_study_id>
    <nct_id>NCT01772888</nct_id>
  </id_info>
  <brief_title>Chewing Efficiency Measured by a Two Colour Chewing Gum Test in Amyotrophic Lateral Sclerosis (ALS) Patients?</brief_title>
  <official_title>Chewing Efficiency Measured by a Two Colour Chewing Gum Test: a Marker of Insufficient Nutritional Intakes and Percutaneous Gastrostomy (PEG) Necessity in ALS Patients?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study aims: The primary aim is to determine whether chewing efficiency, determined by a
      two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study center: University Hospitals of Geneva Study type: Cohort study with matched controls
      Study population: 25 ALS patients included in the multidisciplinary cohort study of the
      University Hospital Geneva between October 2012 and October 2014 and followed for 3 years
      maximum and 25 controls, matched for age, sex and dental status.

      Study duration: Inclusion from October 2012 to October 2016. Follow-up for 3 years.

      Study hypothesis: Chewing efficiency, maximum bite and lip force decrease with time in ALS
      patients and may be a marker of texture adaptation and PEG necessity.

      Study aims: The primary aim is to determine whether chewing efficiency, determined by a
      two-colour mixing ability test, and maximum bite and lip force decrease in ALS patients.

      The secondary aims are to determine, in ALS patients, whether:

        -  Maximum bite and lip force decrease.

        -  Chewing efficiency, maximum bite and lip force decrease more in ALS patients with bulbar
           than with spinal onset.

        -  Chewing efficiency and bite force correlate with energy intakes, nasofibroscopic
           assessment, and a validated swallowing questionnaire.

        -  Saliva volume increases with time and progression of disease and influences masticatory
           efficiency.

        -  Saliva volume is associated with nasofibroscopy assessment.

      Methods : Every three months, we will perform:

        -  As part of the ongoing cohort study (already accepted by the Ethical Committee)
           calculation of energy intakes through a 24h recall, nasofibroscopy, swallowing
           questionnaire and score of disease severity.

        -  As part of this study: assessment of dental status at first visit, chewing efficiency
           test by a with a colour mixing ability test, maximum voluntary bite and lip force,
           saliva volume and calculation of a 3-day dietary recall instead of a 24h recall.

      Statistics: Evolutions with time and between groups, of chewing efficiency, bite and lip
      force will be assessed by repeated measures ANOVA. Correlations between two continuous
      variables will be examined by Spearman's correlation coefficients at the different time
      points. Correlations between a continuous variable and a binary variable (nasofibroscopic
      assessment) will be explored by logistic regression with mixed effect model.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">October 2019</completion_date>
  <primary_completion_date type="Anticipated">October 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>- Chewing efficiency</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Lip force</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bite force</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Calorie and protein intakes</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Saliva volume</measure>
    <time_frame>5 years</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">25</enrollment>
  <condition>Amyotrophic Lateral Sclerosis 11</condition>
  <arm_group>
    <arm_group_label>Patients with ALS</arm_group_label>
    <description>All subjects aged &gt; 18 years, diagnosed with an ALS and included in the multidisciplinary follow-up of the HUG at time of diagnosis will be considered and included, if possible, at their first visit.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Healthy age and gender-matched subjects</arm_group_label>
    <description>Controls matched for age and gender and dental status and without a medical history for neurological or otolaryngologic disease (1 control for 1 patient). They will be recruited among hospital staff and patients of the dental school.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        ALS patients participating in the cohort study of the University Hospital Geneva
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ALS patients

          -  &gt; 18 years

          -  Participation in the cohort study

        Exclusion Criteria:

          -  Refusal of participating in the cohort study

          -  Presence of PEG
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Laurence Genton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Laurence Genton, MD</last_name>
    <phone>+41223729344</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Claude Pichard, MD PhD</last_name>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Laurence Genton, MD</last_name>
    </contact>
    <investigator>
      <last_name>Laurence Genton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Valérie Viatte</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Véronique Karsegard</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Pichard, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dimitrios Samaras, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Schimmel Martin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frauke Müller, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anne-Chantal Héritier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ruxandra Iancu Ferfoglia, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Paul Janssens, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Igor Leuchter, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Dan Adler, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Schimmel M, Christou P, Herrmann F, Müller F. A two-colour chewing gum test for masticatory efficiency: development of different assessment methods. J Oral Rehabil. 2007 Sep;34(9):671-8.</citation>
    <PMID>17716266</PMID>
  </reference>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 17, 2013</study_first_submitted>
  <study_first_submitted_qc>January 17, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 21, 2013</study_first_posted>
  <last_update_submitted>May 2, 2018</last_update_submitted>
  <last_update_submitted_qc>May 2, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital, Geneva</investigator_affiliation>
    <investigator_full_name>Genton Graf Laurence</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sclerosis</mesh_term>
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

